CUV 0.31% $14.55 clinuvel pharmaceuticals limited

The choice to appoint Peter Vaughan appears to be a commendable...

  1. 31 Posts.
    lightbulb Created with Sketch. 10
    The choice to appoint Peter Vaughan appears to be a commendable move. It seems like Peter Vaughan has experience in IPO listings, share registries, etc. Accordingly, his expertise could play a pivotal role in steering Clinuvel toward an upgraded US ADR listing. Currently, Clinuvel resides on the pink sheets in the US. By upgrading their listing, Clinuvel could attract a fresh wave of investor interest and capital as well as dramatically increased trading volume. It is an essential and inevitable move for the Company in my opinion.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$14.55
Change
-0.045(0.31%)
Mkt cap ! $725.6M
Open High Low Value Volume
$14.76 $14.76 $14.46 $329.4K 22.62K

Buyers (Bids)

No. Vol. Price($)
3 145 $14.51
 

Sellers (Offers)

Price($) Vol. No.
$14.54 19 1
View Market Depth
Last trade - 10.55am 31/07/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.